ReviewCancers2025

Treatment Selection for Patients with HER2-Negative Metastatic Gastric Cancer Expressing Claudin 18.2 and PD-L1.

Yusuke Miyajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.